King's College London

Research portal

REBEL: A randomised phase I/II trial of lenalidomide and rituximab with or without bendamustine in patients > 18 years with relapsed follicular lymphoma

Project: ResearchResearch Contract

Funder

Status: Active

Date:

Funding type: Research Contract

Investigators

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454